Glutamine Metabolism Mediates Sensitivity to Respiratory Complex II Inhibition in Acute Myeloid Leukemia
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glutamine Metabolism Mediates Sensitivity to Respiratory Complex II Inhibition in Acute Myeloid Leukemia
Authors
Keywords
-
Journal
MOLECULAR CANCER RESEARCH
Volume 20, Issue 11, Pages 1659-1673
Publisher
American Association for Cancer Research (AACR)
Online
2022-08-23
DOI
10.1158/1541-7786.mcr-21-1032
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Very long chain fatty acid metabolism is required in acute myeloid leukemia
- (2021) Matthew Tcheng et al. BLOOD
- Interim Analysis of a Phase II Study of the Glutaminase Inhibitor Telaglenastat (CB-839) in Combination with Azacitidine in Advanced Myelodysplastic Syndrome (MDS)
- (2020) Veronica A Guerra et al. BLOOD
- The mitochondrial peptidase, neurolysin, regulates respiratory chain supercomplex formation and is necessary for AML viability
- (2020) Sara Mirali et al. Science Translational Medicine
- Hybrid de novo genome assembly of red gromwell (Lithospermum erythrorhizon) reveals evolutionary insight into shikonin biosynthesis
- (2020) Robert P. Auber et al. Horticulture Research
- Venetoclax causes metabolic reprogramming independent of BCL-2 inhibition
- (2020) Alba Roca-Portoles et al. Cell Death & Disease
- The role of mitochondrial proteases in leukemic cells and leukemic stem cells
- (2020) Sara Mirali et al. Stem Cells Translational Medicine
- Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem Cells
- (2020) Courtney L. Jones et al. Cell Stem Cell
- Extinguishing the Embers: Targeting AML Metabolism
- (2020) Rachel Culp-Hill et al. TRENDS IN MOLECULAR MEDICINE
- Cysteine depletion targets leukemia stem cells through inhibition of electron transport complex II
- (2019) Courtney L. Jones et al. BLOOD
- Shikonin derivatives for cancer prevention and therapy
- (2019) Joelle C. Boulos et al. CANCER LETTERS
- Targeting Glutamine Metabolism and Redox State for Leukemia Therapy
- (2019) Mark A. Gregory et al. CLINICAL CANCER RESEARCH
- Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia
- (2019) Irène Baccelli et al. CANCER CELL
- Anti-leukemia effect of vitamin K3 is mediated through mitochondrial complexes I and II
- (2019) Medhat Ibrahim et al. LEUKEMIA & LYMPHOMA
- High extracellular lactate causes reductive carboxylation in breast tissue cell lines grown under normoxic conditions
- (2019) Arthur Nathan Brodsky et al. PLoS One
- Analysis of the Mechanisms of Action of Naphthoquinone-Based Anti-Acute Myeloid Leukemia Chemotherapeutics
- (2019) Michelle H. Lee et al. MOLECULES
- Inhibition of mitochondrial translation overcomes venetoclax resistance in AML through activation of the integrated stress response
- (2019) David Sharon et al. Science Translational Medicine
- Glutaminolysis is a metabolic dependency in FLT3ITDacute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition
- (2018) Paolo Gallipoli et al. BLOOD
- Rewiring of Glutamine Metabolism Is a Bioenergetic Adaptation of Human Cells with Mitochondrial DNA Mutations
- (2018) Qiuying Chen et al. Cell Metabolism
- Human diseases associated with defects in assembly of OXPHOS complexes
- (2018) Daniele Ghezzi et al. Essays in Biochemistry
- NADH Shuttling Couples Cytosolic Reductive Carboxylation of Glutamine with Glycolysis in Cells with Mitochondrial Dysfunction
- (2018) Edoardo Gaude et al. MOLECULAR CELL
- Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours
- (2018) Javier Garcia-Bermudez et al. NATURE CELL BIOLOGY
- Aspartate is an endogenous metabolic limitation for tumour growth
- (2018) Lucas B. Sullivan et al. NATURE CELL BIOLOGY
- An inhibitor of oxidative phosphorylation exploits cancer vulnerability
- (2018) Jennifer R. Molina et al. NATURE MEDICINE
- Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells
- (2018) Courtney L. Jones et al. CANCER CELL
- Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia
- (2018) Daniel A. Pollyea et al. NATURE MEDICINE
- The mitochondrial respiratory chain is essential for haematopoietic stem cell function
- (2017) Elena Ansó et al. NATURE CELL BIOLOGY
- Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
- (2017) Thomas Farge et al. Cancer Discovery
- Characterization and metabolic synthetic lethal testing in a new model of SDH-loss familial pheochromocytoma and paraganglioma
- (2017) John Smestad et al. Oncotarget
- Rule of five in 2015 and beyond: Target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions
- (2016) Christopher A. Lipinski ADVANCED DRUG DELIVERY REVIEWS
- 18 FDG-PET/CT: 21st century approach to leukemic tumors in 124 cases
- (2016) Isabel Cunningham et al. AMERICAN JOURNAL OF HEMATOLOGY
- Disease-Causing SDHAF1 Mutations Impair Transfer of Fe-S Clusters to SDHB
- (2016) Nunziata Maio et al. Cell Metabolism
- Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia
- (2016) M. Konopleva et al. Cancer Discovery
- Fundamentals of cancer metabolism
- (2016) R. J. DeBerardinis et al. Science Advances
- AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress
- (2015) S. Sriskanthadevan et al. BLOOD
- Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition
- (2015) N. Jacque et al. BLOOD
- Mitochondrially targeted vitamin E succinate efficiently kills breast tumour-initiating cells in a complex II-dependent manner
- (2015) Bing Yan et al. BMC CANCER
- Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia
- (2015) Alicia Cole et al. CANCER CELL
- An Essential Role of the Mitochondrial Electron Transport Chain in Cell Proliferation Is to Enable Aspartate Synthesis
- (2015) Kıvanç Birsoy et al. CELL
- Supporting Aspartate Biosynthesis Is an Essential Function of Respiration in Proliferating Cells
- (2015) Lucas B. Sullivan et al. CELL
- Evolution of Mitochondria as Signaling Organelles
- (2015) Navdeep S. Chandel Cell Metabolism
- Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine
- (2015) Lili Guo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Acute Myeloid Leukemia
- (2015) Hartmut Döhner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism
- (2015) Charlotte Lussey-Lepoutre et al. Nature Communications
- An Oxidative Stress Mechanism of Shikonin in Human Glioma Cells
- (2014) Jen-Tsung Yang et al. PLoS One
- Oxidation of Alpha-Ketoglutarate Is Required for Reductive Carboxylation in Cancer Cells with Mitochondrial Defects
- (2014) Andrew R. Mullen et al. Cell Reports
- Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
- (2014) William W Wheaton et al. eLife
- Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre- and postconditioning
- (2013) Stefan Dröse BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells
- (2013) Eleni D. Lagadinou et al. Cell Stem Cell
- Targeting the Mitochondrial Electron Transport Chain Complexes for the Induction of Apoptosis and Cancer Treatment
- (2013) Jakub Rohlena et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Reductive glutamine metabolism is a function of the α-ketoglutarate to citrate ratio in cells
- (2013) Sarah-Maria Fendt et al. Nature Communications
- FLT3 mutations in acute myeloid leukemia: what is the best approach in 2013?
- (2013) M. Levis Hematology-American Society of Hematology Education Program
- Mitochondrial complex II, a novel target for anti-cancer agents
- (2012) Katarina Kluckova et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Shikonin Directly Targets Mitochondria and Causes Mitochondrial Dysfunction in Cancer Cells
- (2012) Benjamin Wiench et al. Evidence-based Complementary and Alternative Medicine
- Cancer-associated Isocitrate Dehydrogenase Mutations Inactivate NADPH-dependent Reductive Carboxylation
- (2012) Roberta Leonardi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Understanding mitochondrial complex I assembly in health and disease
- (2011) Masakazu Mimaki et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia
- (2011) Marko Škrtić et al. CANCER CELL
- Reductive carboxylation supports growth in tumour cells with defective mitochondria
- (2011) Andrew R. Mullen et al. NATURE
- Inhibitors of Succinate: Quinone Reductase/Complex II Regulate Production of Mitochondrial Reactive Oxygen Species and Protect Normal Cells from Ischemic Damage but Induce Specific Cancer Cell Death
- (2011) Stephen J. Ralph et al. PHARMACEUTICAL RESEARCH
- Suppression of Tumor Growth In vivo by the Mitocan -tocopheryl Succinate Requires Respiratory Complex II
- (2009) L.-F. Dong et al. CLINICAL CANCER RESEARCH
- Mitochondrial Respiratory Complex I: Structure, Function and Implication in Human Diseases
- (2009) Lokendra Sharma et al. CURRENT MEDICINAL CHEMISTRY
- Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction
- (2009) Ismael Samudio et al. JOURNAL OF CLINICAL INVESTIGATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation